US Patent Issued to Georgetown University on March 18 for "Treating non-alcoholic steatohepatitis with cck inhibitors" (Pennsylvania Inventor)

ALEXANDRIA, Va., March 19 -- United States Patent no. 12,251,364, issued on March 18, was assigned to Georgetown University (Washington).

"Treating non-alcoholic steatohepatitis with cck inhibitors" was invented by Jill P. Smith (Camp Hill, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods for treating nonalcoholic steatohepatitis (NASH) in a subject, comprising administering to a subject having NASH an effective amount of a CCK receptor inhibitor."

The patent was filed on Nov. 5, 2019, under Application No. 17/291,681.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml...